Home
→
Browsing by Author

Browsing by Author "Garcia-Retortillo, Montserrat"

Now showing items 1-9 of 9

Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years

Puigvehí, Marc; Hernández, Juanjo; Broquetas, Teresa; Coll Estrada, Susanna; Garcia-Retortillo, Montserrat; Cañete Hidalgo, Nuria; Giménez Romaní, Maria Dolors; Garcia, Mar; Bory Ros, Felipe; Salvadó, Margarita; Solà Lamoglia, Ricard; Carrión Rodríguez, José Antonio (Public Library of Science (PLoS), 2016)

INTRODUCTION & AIMS: Cryopreservation of serum samples is a standard procedure for biomedical research in tertiary centers. However, studies evaluating the long-term biological stability of direct liver fibrosis markers ...
Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH)

Jiménez, César; Garcia-Retortillo, Montserrat; Cirera Lorenzo, Isabel; Cañete Hidalgo, Nuria; Vargas, Víctor (Wiley, 2022)

Background & aims: Alcoholic hepatitis (AH) is associated with a high incidence of infection and mortality. Rifaximin reduces bacterial overgrowth and translocation. We aimed to study whether the administration of rifaximin ...
Follow-up evaluation of patients with liver test abnormalities detected during SARS-CoV2 infection

Canillas, Lidia; Broquetas, Teresa; Carrión Rodríguez, José Antonio; Pagano, Giulia; Soriano, Agnès; Garrido, Esther; Fernández, Rosa; Viu, Ana; Romero, Judit; Díaz,Gemma; Cañete Hidalgo, Nuria; Coll Estrada, Susanna; Naranjo‐Hans, Dolores; Bessa Caserras, Xavier; Garcia-Retortillo, Montserrat; Puigvehí, Marc (Wiley, 2022)

Abnormal liver function tests (A-LFTs) during admission for coronavirus disease-19 (COVID-19) are frequent, but its evolution after COVID-19 resolution remains unexplored. We evaluated factors related to A-LFTs during ...
Global real-world evidence of sofosbuvir/velpatasvir as a highly effective treatment and elimination tool in people with hepatitis C infection experiencing mental health disorders

Wedemeyer, Heiner; Garcia-Retortillo, Montserrat; Milligan, Scott (MDPI, 2022)

Hepatitis C virus (HCV) is prevalent in people with mental health disorders, a priority population to diagnose and cure in order to achieve HCV elimination. This integrated analysis pooled data from 20 cohorts in seven ...
Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients

Broquetas, Teresa; Garcia-Retortillo, Montserrat; Micó, Miquel; Canillas, Lidia; Puigvehí, Marc; Cañete Hidalgo, Nuria; Coll Estrada, Susanna; Viu, Ana; Hernández, Juan José; Bessa Caserras, Xavier; Carrión Rodríguez, José Antonio (Baishideng Publishing Group, 2020)

Background: Hepatitis B e antigen-negative chronic hepatitis B patients under nucleos(t)ids analogues (NAs) rarely achieve hepatitis B surface antigen (HBsAg) loss. Aim: To evaluate if the addition of pegylated interferon ...
Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial

Radosevic, Aleksandar; Quesada Diez, Rita; Serlavos, Clara; Sánchez, Juan; Zugazaga Cortázar, Ander; Sierra, Ana; Coll Estrada, Susanna; Busto Barrera, Marcos; Aguilar, Guadalupe; Flores Pereyra, Daniel; Arce, Javier; Maiques LLacer, José María; Garcia-Retortillo, Montserrat; Carrión Rodríguez, José Antonio; Visa Turmo, Laura; Villamonte, Maria; Pueyo Périz, Eva M.; Sánchez Velázquez, Patricia, 1985-; Grande Posa, Luís; Burdío Pinilla, Fernando (Nature Research, 2022)

Microwave (MWA) and radiofrequency ablation (RFA) are main ablative techniques for hepatocellular carcinoma (HCC) and colorectal liver metastasis (MT). This randomized phase 2 clinical trial compares the effectiveness of ...
On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty

Broquetas, Teresa; Hernández, Juan José; Garcia-Retortillo, Montserrat; Canillas, Lidia; Puigvehí, Marc; Cañete Hidalgo, Nuria; Coll Estrada, Susanna; Viu, Ana; Garrido, Esther; Micó, Miquel; Bessa Caserras, Xavier; Carrión Rodríguez, José Antonio (Elsevier, 2022)

Background: Nucleos(t)ide analogues withdrawal may improve HBsAg loss rates. However, conditions to select patients are not well established. Aims: to evaluate the impact of HBsAg kinetics before treatment interruption on ...
Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases

Ginès, Pere; Garcia-Retortillo, Montserrat; Krag, Aleksander; LiverScreen Consortium Investigators (Wiley, 2022)

Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non-alcoholic fatty liver disease and alcohol-related ...
Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues

Broquetas, Teresa; Garcia-Retortillo, Montserrat; Hernández, Juanjo; Puigvehí, Marc; Cañete Hidalgo, Nuria; Coll Estrada, Susanna; Cabrero Daniel, Beatriz; Giménez Romaní, Maria Dolors; Solà Lamoglia, Ricard; Carrión Rodríguez, José Antonio (Public Library of Science (PLoS), 2017)

BACKGROUND: HBeAg-negative chronic hepatitis B patients require long-term nucleos(t)ide analogues(NAs) because loss of surface antigen (HBsAg) is unusual. Low quantitative HBsAg (qHBsAg) levels can identify patients with ...

Now showing items 1-9 of 9

Search DSpace

Advanced Search

Browse

All of DSpace

My Account

Compliant to Partaking

Browsing by Author "Garcia-Retortillo, Montserrat"

Browsing by Author "Garcia-Retortillo, Montserrat"

Search DSpace

Browse

All of DSpace

My Account